Evidence for a role of dopaminergic mechanisms in the immunostimulating effect of μ-opioid receptor agonist DAGO

International Journal of Neuroscience

Volumn 113, Issue 10, 2003, Pages 1381-1394

  Devoino, Lidia ^a   Cheido, Margarita ^a   Alperina, Elizaveta ^a   Idova, Galina ^a  

^a SCIENTIFIC RESEARCH INSTITUTE OF PHYSIOLOGY AND BASIC MEDICINE   (Russian Federation)

Author keywords

opioid receptors; Dopaminergic systems; Hypophysis; Neuroimmunostimulation; The nuclei caudatus and accumbens

Indexed keywords

DOPAMINE 2 RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; HALOPERIDOL; MU OPIATE RECEPTOR AGONIST;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ERYTHROCYTE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NEUROIMMUNOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; RAT; SPLEEN; SPLEEN CELL;

ANALGESICS, OPIOID; ANIMALS; CEREBELLAR NUCLEI; DOPAMINE; DOPAMINE ANTAGONISTS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ERYTHROCYTES; HALOPERIDOL; HEMOLYTIC PLAQUE TECHNIQUE; HYPOTHALAMUS; IMMUNIZATION; IMMUNOGLOBULIN M; MALE; MICE; MICE, INBRED CBA; NEUROIMMUNOMODULATION; NUCLEUS ACCUMBENS; PITUITARY GLAND; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; ROSETTE FORMATION; SHEEP; SPECIES SPECIFICITY; SPLEEN;

EID: 0242267450     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450390231437     Document Type: Article

References (43)

1. Alperina, E. L., & Idova, G. V. (1990). Central mechanism of the neurotransmitter system interaction in neuroimmunomodulation. Russian Journal of Physiology, 76(4), 453-458 (in Russian).
2. Basu, S., & Dasgupta, P. S. (2000). Dopamine, a neurotransmitter, influences the immune system. Neuroimmunology, 102(2), 113-124.
3. Bliznakov, E. G. (1980). Serotonin and its precursor as modulators of the immunological responsiveness in mice. Journal of Medicine, 11, 81-105.
4. Chuang, T. K., Killam, K. F. Jr., Chuang, L. F., Kung, H. F., Sheng, W. S., Chao, C. C., Yu, L., & Chuang, R. Y. (1995). Mu opioid receptor gene expression in immune cells. Biochemistry and Biophysics Research Communication, 216(3), 922-930.
5. Cunningham, A. J. (1965). A method of increased sensitivity for detecting single antibody-forming cells. Nature, 207, 1106-1107.
6. Cunningham, S. T., & Kelley, A. E. (1992). Opiate infusion into nucleus accumbens: Contrasting effects on motor activity and responding for conditioned reward. Brain Research, 588, 104-114.
7. Cheido, M. A., & Idova, G. V. (1998). The effect of opioid peptides on the immunomodulation processes. Russian Journal of Physiology, 84(4,), 385-390 (in Russian).
8. Cheido, M. A., Idova, G. V., & Devoino, L. V. (1993). Serotonin-dependent suppression of immune response by kappa-opiate receptors. Bulletin of Experimental Biology and Medicine, 9, 291-292 (in Russian).
9. Cheido, M. A., Idova, G., & Devoino, L. (1996). Involvement of delta-opioid receptors in immunosuppression. International Journal of Neuroscience, 84, 195-203.
10. Devoino, L., Alperina, E., Galkina, O., & Ilyutchenok, R. (1997). Involvement of brain dopaminergic structures in neuroimmunomodulation. International Journal of Neuroscience, 93(3-4), 213-228.
11. Devoino, L., Alperina, E., & Idova, G. (1988). Dopaminergic stimulation of the immune reaction: Interaction of serotoninergic and dopaminergic systems in neuroimmunomodulation. International Journal of Neuroscience, 40, 271-288.
12. Devoino, L., Elisseva, L., Idova, G., & Cheido, M. (1975). 5-hydroxytryptophan effect on the development of the immune response: IgM- and IgG-antibodies and rosette formation in primary and secondary responses. European Journal of Immunology, 5, 394-399.
13. Devoino, L. V., Idova, G. V., Alperina, E. L., & Cheido, M. A. (1994). Brain neuromediator systems in the immune response control: Pharmacological analysis of pre- and postsynaptic mechanisms. Brain Research, 633, 267-274.
14. Devoino, L. V., & Ilyutchenok, R. Yu. (1983). Monoaminergic systems in the control of immune response (serotonin, dopamine). Novosibirsk: Nauka (in Russian).
15. Devoino, L.V., & Ilyutchenok, R. Yu. (1993). Neuromediator systems in psychoneuro-immunomodulation: Dopamine, serotonin, neuropeptides. Novosibirsk: CERIS (in Russian).
16. Di Chiara, G., & Imperato, A. (1988). Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. Journal of Pharmacology and Experimental Therapeutics, 244, 1067-1080.
17. Ding, Y. Q., Kaneko, T., Nomura, S., & Mizuno, N. (1996). Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. Journal of Comparative Neurology, 367(3), 375-402.
18. Dourmap, N., Clero, N., & Costentin, J. (1997). Involvement of holinergic neurons in the release of dopamine elicited by stimulation of mu-opioid receptors in striatum. Brain Research, 749(2), 295-300.
19. Handa, B. K., Lane, A. C., Lord, J. A. H., Morgan, B. A., Rance, M. J., & Smith, C. F. (1981). Analogues of β-LPH61-64 possessing selective agonist activity at μ-opiate receptors. European Journal of Pharmacology, 70, 531-540.
20. Ilyutchenok, R. Yu., & Devoino, L. V. (1968). Influence of some drugs on the immune response. II. Effects of serotonin, 5-hydroxytryptophan, reserpine and iproniazid on delayed hypersensitivity. European Journal of Pharmacology, 4, 449-456.
21. Inghamn, C. A., Hood, S. H., & Abruthnott, G. W. (1991). A light and electron microscopical study of enkephalin-immunoreactive structures in the rat neostriatum after removal of the nigristriatal dopaminergic pathway. Neuroscience, 42(3), 715-730.
22. Jackson, J. K., Cross, R. J., Marcesbery, W. K., & Brooks, W. H. (1985). Influence of serotonin on the immune response. Immunology, 54, 505-512.
23. Kalivas, P. W., & Duffu, P. (1990). Effect of acute and daily neurotensin and enkephalin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. Journal of Neuroscience, 10, 2940-2949.
24. Kamata, K. (1987). Pharmacological studies on the interrelation between the dopaminergic, GABAergic and opioid systems. Japan Journal of Pharmacology, 45, 439-447.
25. Konig, J. F. R., & Klippel, R. A. (1963). The rat brain. A stereotaxis atlas of the forebrain and lower parts of the brain stem. Baltimore.
26. Levant, B., & Vansell, N. R. (1997). In vivo occupancy of D2 dopamine receptors by nafadotride. Neuropsychopharmacology, 17, 67-71.
27. MacLennan, A. J., Atmadia, S., Lee, N., & Fibiger, H. C. (1998). Chronic haloperidol administration increases the density of D2 dopamine receptors in the medial prefrontal cortex of the rat. Psychopharmacology, 95, 255-257.
28. Mansour, A., Khachaturian, H., Lewis, M. E., Akil, H., & Watson, S. J. (1988). Anatomy of CNS opioid receptors. Trends Neuroscience, 11, 308-314.
29. Mansour, A., Fox, C. A., Burke, S., Akill, H., & Watson, S. J. (1995). Immunohistochemical localization of the cloned mu-opioid receptor in the rat CNS. Journal of Chemistry and Neuroanatomy, 8, 283-305.
30. Marshall, J. F., O'Dell, S. J., Navarette, R., & Rosenstein, A. J. (1990). Dopamine high-affinity transport sity topagraphy in rat brain: Major differences between dorsal and ventral striatum. Neuroscience, 37(1), 11-21.
31. Nelson, C. J., Schneider, G. M., & Lysle, D. T. (2000). Involvement of central μ-but not δ- or κ-opioid receptors in immunomodulation. Brain, Behavior, and Immunity, 14(3), 170-184.
32. Neveu, P. J. (1993). Brain lateralization and immunomodulation. International Journal of Neuroscience, 70(1-2), 135-143.
33. Nistico, G., Caroleo, M. C., Arbitro, M., & Pulvirenti, L. (1994a). Evidence for an involvement of dopamine D1 receptors in the limbic system in the control of immune mechanisms. Neuroimmunomodulation, 1(3), 174-3180.
34. Nistico, G., Caroleo, M. C., Arbitro, M., & Pulvirenti, L. (1994b). Dopamine D1 receptors in the amigdala enhance the immune response in the rat. Annals of the New York Academy Science, 741, 316-323.
35. Radulovic, J., & Jankovic, B. D. (1994). Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat. Brain Research, 661, 189-195.
36. Radulovic, J., Mancev, Z., Stanojevic, S., Vasiljevic, T., Kovacavic-Jovanovic, V., & Pesic, G. (1996). Modulation of humoral immune response by central administration of leucine-enkephalin: Effect of mu, delta and kappa opioid receptor antagonists. Journal of Neuroimmunology, 65(2), 155-161.
37. Seeman, P. (1992). Dopamine receptor sequences: Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology, 1, 261-284.
38. Seeman, P., & Ulpian, C. (1988). Dopamine D-1 and D-2 receptor selectivities of agonists and antagonists. Advances of Experimental Medicine and Biology, 235, 55-63.
39. Sharif, N. A., & Hugher, J. (1989). Discrete mapping of brain mu and delta opioid receptors using selective peptides: Quantitative autoradiography, species differences and comparison with kappa receptors. Peptides, 10(3), 499-3522.
40. Swerdlow, N. R., Amarlic, M., & Koob, G. F. (1987). Nucleus accumbens opiatedopamine interaction and locomotor activation in the rat: Evidence for a presynaptic locus. Pharmacology, Biochemistry and Behaviour, 26, 765-770.
41. Trulson, M. E., & Arasteh, K. (1985). Morphine increases the activity of midbrain dopamine neurons in vitro. European Journal of Pharmacology, 114, 105-109.
42. Ukai, M., Tojoshi, T., & Kameyama, T. (1991). DAGO([d-A1a2,N-Me-Phe4,Gly-ol]enkephalin) specifically reverses apomorphine-induced increases in rearing and grooming behaviors in the mouse. Brain Research, 557, 77-82.
43. Yokoo, H., Yamada, S., Yoshida, M., & Tanaka, T. (1994). Effect of opioid peptides on dopamine release from nucleus accumbens after repeated treatment with methamphetamine. European Journal of Pharmacology, 256, 335-338.